Exchange: NYSE·Updated 07:59 PM EDT
News
all
press releases
HIMS SHAREHOLDER ALERT: Hims & Hers Health, Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Hims & Hers Health, Inc. (Hims or the Company) (NYSE: HIMS) investors concerning the Companys and/or members of its senior managements possible violation of the federal securities laws or other unlawful business...
Business Wire
More News
NYSE: HIMS Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm
NYSE: HIMS Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm NYSE: HIMS Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm PR Newswire RADNOR...
PR Newswire
Berger Montague PC Investigates Hims & Hers Health, Inc.'s Board of Directors for Breach of Fiduciary Duty (NYSE: HIMS)
Berger Montague PC Investigates Hims & Hers Health, Inc.'s Board of Directors for Breach of Fiduciary Duty (NYSE: HIMS) Berger Montague PC Investigates Hims & Hers Health, Inc.'s Board of Directors for Breach of Fiduciary Duty (NYSE: HIMS) PR Newswire PHILADELPHIA, Aug. 12, 2026 PHILADELPHIA, Aug...
PR Newswire
HIMS Stock Snaps 2-Day Climb: Analyst Says Record Subscriber Growth ‘Not Enough’ To Offset Margin Slide
Morningstar’s $23 fair value implies a 25% downside, with a 'Very High Uncertainty' rating.
Stocktwits
Hims & Hers Stock Plunges Post Q2 Earnings Miss, Gross Margin Down
HIMS posts a wider-than-expected loss and weaker gross margin in second-quarter 2026 despite strong revenue growth and a raised full-year outlook.
Zacks
Hims & Hers Health: Investments Necessary For Long-Term Incremental Growth, Says Bullish Analyst
HIMS stock edges lower after mixed Q2 results. Needham analyst maintains Buy rating, raises PT to $42. Company's revenue up 38.2% YoY.read more...
Benzinga
Citi Says Hims & Hers’ Full-Year Outlook Indicates ‘Hefty’ Q4 Earnings Lift, Warns Of Execution Risks
Hims & Hers Health raised its 2026 revenue outlook to between $3.1 billion and $3.3 billion from its earlier guidance between $2.8 billion and $3 billion.
Stocktwits
HIMS Q2 Earnings Call Focuses on AI and Global Expansion
Hims & Hers raises its 2026 revenue outlook as AI boosts engagement, specialty care expands and Eucalyptus extends its international reach despite margin pressure.
Zacks
Why Is Hims & Hers Health Stock Falling Tuesday?
Hims & Hers stock falls after Q2 earnings miss estimates despite beating revenue targets. Here is what drove the stock down.read more...
Benzinga
Why Nasdaq, S&P 500, Dow Futures Are Trading Mixed Overnight Ahead Of Inflation Data
U.S. President Donald Trump said on Monday that he would seek compensation from Iran as part of any peace agreement.
Stocktwits

Advertisement|Remove ads.